Inventor · disambiguated record
Mark A. Depristo
Also filed as: DEPRISTO MARK · DEPRISTO MARK A · DEPRISTO MARK ANDREW
9 granted patents·10 pending applications·75 citations·filing 2014–2023
84Inventor score
Files withLABORATORY CORP AMERICA HOLDINGS7VERILY LIFE SCIENCES LLC4GOOGLE LLC3SYNAPDX CORP3BIGHAT BIOSCIENCES INC2
Top patents by PatentIndex Score
19 records- 0195US10354747B1Deep learning analysis pipeline for next generation sequencingVERILY LIFE SCIENCES LLC·Filed 2017·Granted Jul 16, 2019·60 cites·20 claims
- 0285US9176113B1Methods and systems for determining autism spectrum disorder riskSYNAPDX CORP·Filed 2015·Granted Nov 3, 2015·7 cites·5 claims
- 0384US12272431B2Detecting false positive variant calls in next-generation sequencingVERILY LIFE SCIENCES LLC·Filed 2022·Granted Apr 8, 2025·1 cites·18 claims
- 0483US11335438B1Detecting false positive variant calls in next-generation sequencingVERILY LIFE SCIENCES LLC·Filed 2017·Granted May 17, 2022·6 cites·20 claims
- 0576US2024019417A1Methods and Systems for Determining Autism Spectrum Disorder RiskLABORATORY CORP AMERICA HOLDINGS·Filed 2023·Application pending·0 cites
- 0672US2023293461A1Metabolic Markers of Attention Deficit Hyperactivity DisorderLABORATORY CORP AMERICA HOLDINGS·Filed 2023·Application pending·0 cites
- 0771US2024230622A9Methods and Systems for Determining Autism Spectrum Disorder RiskLABORATORY CORP AMERICA HOLDINGS·Filed 2023·Application pending·0 cites
- 0866US2020188335A1Metabolic Markers of Attention Deficit Hyperactivity DisorderLABORATORY CORP AMERICA HOLDINGS·Filed 2019·Application pending·0 cites
- 0965US10041932B2Methods and systems for determining autism spectrum disorder riskLABORATORY CORP AMERICA HOLDINGS·Filed 2015·Granted Aug 7, 2018·1 cites·8 claims
- 1063US11674948B2Methods and systems for determining autism spectrum disorder riskLABORATORY CORP AMERICA HOLDINGS·Filed 2018·Granted Jun 13, 2023·0 cites·17 claims
- 1162US2024059759A1Sars-cov(-2) spike glycoprotein-binding domains and polypeptides comprising the same and use of the sameBIGHAT BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1262US2025313630A1Ph-selective anti-cd3 antibodies and use of the sameBIGHAT BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1359US10525020B2Metabolic markers of attention deficit hyperactivity disorderLABORATORY CORP AMERICA HOLDINGS·Filed 2016·Granted Jan 7, 2020·0 cites·12 claims
- 1449US2016091481A1Methods and systems for determining autism spectrum disorder riskSYNAPDX CORP·Filed 2015·Application pending·0 cites
- 1548US2015294081A1Methods and systems for determining autism spectrum disorder riskSYNAPDX CORP·Filed 2014·Application pending·0 cites
- 1646US2022253747A1Likelihood Ratios for Out-of-Distribution DetectionGOOGLE LLC·Filed 2020·Application pending·0 cites
- 1745US12353999B2Predicting biological functions of proteins using dilated convolutional neural networksGOOGLE LLC·Filed 2020·Granted Jul 8, 2025·0 cites·20 claims
- 1843US10892036B1Systems and methods for determining the identity of alleles from genomic sequencing dataVERILY LIFE SCIENCES LLC·Filed 2017·Granted Jan 12, 2021·0 cites·13 claims
- 1938US2019295688A1Processing biological sequences using neural networksGOOGLE LLC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark A. Depristo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →